Mutual of America Capital Management’s Kyntra Bio KYNB Stock Holding History
Bought
Maintained
Sold
Other funds holding KYNB
FCM
Mutual of America Capital Management's KYNB Position: Q3 2021 in Review
Mutual of America Capital Management sold out of Kyntra Bio (KYNB) in Q3 2021, closing a stake of 2,710 shares — an estimated $1.8M sold.
Mutual of America Capital Management first reported a position in KYNB in Q2 2018 and held it in 13 quarters. The position peaked at $2.99M in Q2 2020. 164 funds tracked by Wall St. Rank hold KYNB as of Q3 2021.
- Mutual of America Capital Management reported no remaining Kyntra Bio position as of Q3 2021 after selling out during the quarter.
- Mutual of America Capital Management sold 2,710 Kyntra Bio shares in Q3 2021, an estimated $1.8M.
- Mutual of America Capital Management first reported a position in Kyntra Bio in Q2 2018 and held it in 13 quarters.
- Mutual of America Capital Management's Kyntra Bio position peaked at $2.99M in Q2 2020.
- 164 funds tracked by Wall St. Rank held Kyntra Bio as of Q3 2021.
Based on Mutual of America Capital Management's 13F filing for Q3 2021, filed 10 Nov 2021.